Navigation Links
Therapure Biopharma Inc. Commissions its Commercial-Scale Lyophilizer
Date:1/28/2010

Freeze-drying of biopharmaceuticals now available at the Company’s Health Canada licensed facility.

Toronto, ON (PRWEB) Jan. 27, 2010 -- Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced that the Company has completing the commissioning and validation of its commercial-scale pharmaceutical-grade freeze dryer and now offers commercial scale freeze drying (lyophilization) for contract manufacturing of biopharmaceuticals.

Lyophilization is used to convert biopharmaceuticals that are manufactured in an unstable liquid format into a stable, dry powder that can be reconstituted to a liquid format for administration to patients. Lyophilized forms of these life-saving products are more easily handled and stable than their liquid forms and therefore lyophilization is commonly used in the manufacture of these products.

“Until today, commercial-scale lyophilization has not been readily available in Canada,” said Mr. Wellner. “The launch of our commercial-scale lyophilizer, combined with our existing aseptic filling capabilities in vials and bags, significantly broadens the service offering we have for clients,” Mr. Wellner continued.

The new lyophilizer has been integrated into Therapure’s existing aseptic vial filling suite. This integrated suite now includes an automated vial filler, vial transporter, and the 75 square foot lyophilizer. All parts of this automated suite are contained within Class 100 clean space and are fully compliant with Health Canada and FDA GMP requirements The fill suite handles fill volumes ranging from 2ml to 200ml in glass vials with rubber stoppers and capped, and is capable of batch sizes ranging from 35,000 units per shift for smaller vials to 3,000 units per shift for larger vials.

About Therapure Biopharma:

Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies, and packages therapeutic proteins. As a contract development and manufacturing organization (CDMO) Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market.

For more information, please visit: www.therapurebio.com

Media Contact:

Thomas Wellner, President and CEO
Therapure Biopharma Inc.
+1 905-286-6204
ceo(at)therapurebio(dot)com

###

Read the full story at http://www.prweb.com/releases/2010/01/prweb3523854.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Therapure Biopharma Inc. and LFB Biotechnologies Announce Development Services Contract for New Therapeutic Protein
2. Therapure Biopharma Inc. and Akorn, Inc. Announce Strategic Supply Contract
3. Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership
4. Microbix and Therapure Biopharma Form Partnership to Expand Water-Based Supplies to the Pharma Industry
5. Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer
6. PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets
7. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
8. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
9. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
10. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
11. Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... 11, 2016 , ... Life is known for throwing curves. It’s thrown quite ... gather once a year to play softball to raise money through Sun Health ... than 50 players who competed in this year’s softball tournament share a history of ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... and updated its hallmark resource, Infusion Therapy Standards of Practice, to include vascular ... vein illumination with an estimated 85% share of the market, facilitates adherence to ...
(Date:2/11/2016)... ... 11, 2016 , ... Dickinson Insurance & Financial Services continues their commitment to ... support of a local boy named Barrett, who has been fighting ALL leukemia for ... rally support for, all local families dealing with childhood cancer. Information on how to ...
(Date:2/11/2016)... ... 11, 2016 , ... Be Well Medical Group (Be Well) is ... Town at 108 South Columbus St, Suite 201, Alexandria, VA. Be Well Medical Group ... in the convenience of their homes, offices or at the practices’ local office. It ...
(Date:2/11/2016)... ... ... Husted Kicking has completed its Third Annual Husted Kicking College ... 2016 according to kicking coach Michael Husted. , “This event serves as an official ... Indianapolis,” says Husted. “The NFL uses a third party organization to select players for ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... NEW YORK , Feb. 11, 2016 /PRNewswire/ ... a foot-focused suite of products designed to support ... ExoSOLS™, are custom orthotic insoles that combine years ... 1,000 partners in the podiatric field with cutting ... align, and propel . It is supported by ...
(Date:2/11/2016)... , February 11, 2016 ... Market Report 2016 research report provides information on ... development status with crucial statistical data and information ... http://www.deepresearchreports.com/142870.html . --> Complete report on ... companies and supported with 296 tables and figures ...
(Date:2/10/2016)... 2016   Genomic Health, Inc. (Nasdaq: GHDX ) ... year ended December 31, 2015. --> ... 2015, compared with $69.1 million in the fourth quarter of 2014, ... increased 9 percent compared with the same period in the prior ... was $63.9 million in the fourth quarter of 2015, an increase ...
Breaking Medicine Technology: